Anxiety and depression in patients aged 80 years and older following aortic valve therapy. A six-month follow-up study.
Leslie S P EideBengt FridlundKarl Ove HufthammerRune HaaverstadErik J S PackerAnette H RanhoffDavid R ThompsonTone M Norekvålnull nullPublished in: Aging clinical and experimental research (2023)
SAVR or TAVI in patients ≥ 80 years was associated with anxiety reduction between baseline and follow-up. For depression, there was no evidence of change over time in either treatment group.
Keyphrases
- aortic valve
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- peritoneal dialysis
- prognostic factors
- depressive symptoms
- stem cells
- coronary artery disease
- mesenchymal stem cells
- cell therapy
- smoking cessation